Compare Medtronic PLC (MDT) vs Roblox Corp (RBLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Roblox Corp — how do they compare? Medtronic PLC trades at $82.89 (market cap $106.61B), while Roblox Corp trades at $53.37 (market cap $38.13B). The key difference: Medtronic PLC is far larger — about 2.8× Roblox Corp's market cap, and Medtronic PLC pays a 3.46% dividend while Roblox Corp pays none. Which is the better fit depends on your goals.
| MDT | RBLX | |
|---|---|---|
Market Cap | $106.61B | $38.13B |
Sector | Health | Media |
52-Week High | $105.35 | $141.56 |
52-Week Low | $73.75 | $41.30 |
Enterprise Value | $125.36B | $36.71B |
Dividend Yield | 3.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
Roblox trades at $54.08, up 4.64% today, showing positive momentum despite a bearish technical signal. The company continues to demonstrate strong revenue growth with $4.89B in 2025, though it remains unprofitable with a -20.69% net margin. Recent product innovation includes the launch of 'Build,' an AI-powered game creation tool, while facing multiple class-action lawsuits alleging securities fraud between October 2025 and April 2026.
While analyst consensus remains positive with a $59.62 price target and 51% buy ratings, investors face significant risks from ongoing litigation and persistent profitability challenges. The stock's high P/B ratio of 85.65 suggests premium valuation despite negative returns on equity, creating a mixed investment case dependent on future margin improvement.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →
